AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 81 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $50,000 | -59.0% | 21,600 | -15.6% | 0.00% | – |
| Q4 2021 | $122,000 | -40.2% | 25,600 | 0.0% | 0.00% | – |
| Q3 2021 | $204,000 | +14.6% | 25,600 | 0.0% | 0.00% | – |
| Q2 2021 | $178,000 | -3.8% | 25,600 | +9.4% | 0.00% | – |
| Q1 2021 | $185,000 | -1.6% | 23,400 | -2.1% | 0.00% | – |
| Q4 2020 | $188,000 | -1.1% | 23,900 | -10.8% | 0.00% | – |
| Q3 2020 | $190,000 | -17.0% | 26,800 | +8.1% | 0.00% | – |
| Q2 2020 | $229,000 | +387.2% | 24,800 | +148.0% | 0.00% | – |
| Q1 2020 | $47,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Yu Fan | 112,044 | $532,000 | 6.17% |
| Aisling Capital Management LP | 1,691,151 | $8,033,000 | 2.83% |
| Bain Capital Life Sciences Investors, LLC | 2,847,689 | $13,527,000 | 1.07% |
| GREAT POINT PARTNERS LLC | 910,251 | $4,324,000 | 0.96% |
| Samsara BioCapital, LLC | 883,720 | $4,198,000 | 0.81% |
| Sio Capital Management, LLC | 498,500 | $2,368,000 | 0.71% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 245,678 | $1,167,000 | 0.53% |
| Nantahala Capital Management | 2,813,560 | $13,364,000 | 0.47% |
| Altium Capital Management LP | 293,764 | $1,395,000 | 0.38% |
| Lion Point Capital, LP | 300,000 | $1,425,000 | 0.38% |